Hereditary persistence of alpha-fetoprotein

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:168615OMIM:615970R77.2
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hereditary persistence of alpha-fetoprotein (HPAFP) is a rare, benign genetic condition characterized by persistently elevated levels of alpha-fetoprotein (AFP) in the blood throughout life. Alpha-fetoprotein is a protein normally produced in large quantities by the fetal liver during development, with levels typically declining rapidly after birth to very low concentrations in healthy adults. In individuals with HPAFP, AFP levels remain abnormally elevated without any associated disease or clinical symptoms. This condition is clinically significant primarily because elevated AFP levels in adults are commonly used as a tumor marker, particularly for hepatocellular carcinoma (liver cancer), certain germ cell tumors, and other malignancies. Individuals with HPAFP may therefore be subjected to unnecessary and invasive diagnostic investigations if their hereditary condition is not recognized. The condition does not affect any organ system and is not associated with any pathological consequences — it is considered entirely benign. No treatment is required for hereditary persistence of alpha-fetoprotein, as it causes no symptoms or health problems. The primary clinical importance lies in awareness and correct diagnosis to avoid unnecessary cancer workups in affected individuals and their family members. Genetic counseling may be helpful to inform families about the benign nature of the condition. The condition has been linked to mutations affecting the AFP gene regulatory region on chromosome 4q.

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Hereditary persistence of alpha-fetoprotein.

View clinical trials →

No actively recruiting trials found for Hereditary persistence of alpha-fetoprotein at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Hereditary persistence of alpha-fetoprotein community →

No specialists are currently listed for Hereditary persistence of alpha-fetoprotein.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hereditary persistence of alpha-fetoprotein.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hereditary persistence of alpha-fetoproteinForum →

No community posts yet. Be the first to share your experience with Hereditary persistence of alpha-fetoprotein.

Start the conversation →

Latest news about Hereditary persistence of alpha-fetoprotein

No recent news articles for Hereditary persistence of alpha-fetoprotein.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Hereditary persistence of alpha-fetoprotein

What is Hereditary persistence of alpha-fetoprotein?

Hereditary persistence of alpha-fetoprotein (HPAFP) is a rare, benign genetic condition characterized by persistently elevated levels of alpha-fetoprotein (AFP) in the blood throughout life. Alpha-fetoprotein is a protein normally produced in large quantities by the fetal liver during development, with levels typically declining rapidly after birth to very low concentrations in healthy adults. In individuals with HPAFP, AFP levels remain abnormally elevated without any associated disease or clinical symptoms. This condition is clinically significant primarily because elevated AFP levels in ad

How is Hereditary persistence of alpha-fetoprotein inherited?

Hereditary persistence of alpha-fetoprotein follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.